Initiation and change of psychotropic medication regimens among adolescents in inpatient care

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 5, 2007, Pages 701-712

  Warner, Lynn A ^a   Fontanella, Cynthia A ^b   Pottick, Kathleen J ^c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ARTICLE; BIPOLAR DISORDER; BIVARIATE ANALYSIS; CHI SQUARE TEST; CLIMATE; CLINICAL EVALUATION; CLINICAL FEATURE; CORRELATION ANALYSIS; CULTURAL ANTHROPOLOGY; DEMOGRAPHY; DEPRESSION; DRUG USE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON PROFIT HOSPITAL; PARENT; PATIENT; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; STUDENT T TEST; SUICIDAL BEHAVIOR;

ADOLESCENT; CHILD; DATA INTERPRETATION, STATISTICAL; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MULTIVARIATE ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; SOCIOECONOMIC FACTORS;

EID: 35848964379     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0120     Document Type: Article

References (42)

1. Ahsanuddin KM, Ivey JA, Schlotzhauer D, Hall K, Prosen H: Psychotropic medication prescription patterns in 100 hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry 22:361-364, 1983.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington (DC), American Psychiatric Association, 1994.
3. Apter A, Horesh N, Gothelf D, Zalsman G, Erlich Z, Soreni N, Weizman A: Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder. J Affect Disord 75:181-189, 2003.
4. Bobier C, Warwick, M: Factors associated with readmission to adolescent psychiatric care. Aust N Z J Psychiatry 39:600-606, 2005.
5. Cook JA, Heflinger CA, Hoven CW, Kelleher KF, Mulkern V, Paulson RI, Stein-Seroussi A, Fitzgibbon G, Burke-Miller J, Williams M, Kim JB: A multi-site study of Medicaid-funded managed care versus fee-for-service plans' effects on mental health service utilization of children with severe emotional disturbance. J Behav Health Serv Res 31:384-402, 2004.
6. Connor DF, Ozbayrak KR, Harrison RJ, Melloni RH: Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. J Child Adolesc Psychopharmacol 8:27-38, 1998.
7. D'Eramo KS, Prinstein MJ, Freeman J, Grapentine WL, Spirito A: Psychiatric diagnoses and comorbidity in relation to suicidal behavior among psychiatrically hospitalized adolescents. Child Psychiatry Hum Dev 35:21-35, 2004.
8. Dean AJ, McDermott BM, Marshall RT: Psychotropic medication utilization in a child and adolescent mental health service. J Child Adolesc Psychopharmacol 16:273-285, 2006.
9. DeNavas-Walt C, Proctor, BD, Lee CH: U.S. Census Bureau, Current Population Reports, P60-229, Income, Poverty, and Health Insurance Coverage in the United States: 2004, U.S. Government Printing Office, Washington, DC. Accessed at http://www.census.gov/prod/2005pubs/p60-229.pdf, 2005.
10. dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL: Multiple psychotropic medication use for youths: A two-state comparison. J Child Adolesc Psychopharmacol 15:68-77, 2005.
11. Duffy FF, Narrow WE, Rae DS, West JC, Zarin DA, Rubio-Stipec M, Pincus HA, Reiger DA: Concomitant pharmacotherapy among youths treated in routine psychiatric practice. J Child Adolesc Psychopharmacol 15:12-25, 2005.
12. Elixhauser A, Machlin SR, Zodet MW, Chevarley FM, Patel N, McCormick MC, Simpson L: Health care for children and youth in the United States: 2001 annual report on access, utilization, quality, and expenditures. Ambul Pediatr 2:419-437, 2002.
13. Fontanella CA, Zuravin SJ, Burry CL: The effect of a medicaid managed care program on patterns of psychiatric readmission among adolescents: Evidence from Maryland. J Behav Health Serv Res 33:39-52, 2006.
14. Hack S, Chow B: Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol 11:59-67, 2001.
15. Harpaz-Rotem I, Leslie DL, Martin A, Rosenheck RA: Changes in child and adolescent inpatient psychiatric admission diagnoses between 1995-2000. Soc Psychiatry Psychiatr Epidemiol 40:642-647, 2005.
16. He XZ, Lyons JS, Heinemann AW: Modeling crisis decision-making for children in state custody. Gen Hosp Psychiatry 26:378-383, 2004.
17. Hoagwood K, Burns BJ, Kiser L, Ringeisen H, Schoenwald SK: Evidence-based practice in child and adolescent mental health services Psychiatr Serv 52:1179-1189, 2001.
18. nd ed. Chicago, Health Administration Press, 1997.
19. Kaplan SL, Busner J: Prescribing practices of inpatient child psychiatrists under three auspices of care. J Child Adolesc Psychopharmacol 7:275-286, 1997.
20. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M: Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213-235, 2005.
21. Lekhwani M: Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger. J Child Adolesc Psychopharmacol 14:95-103, 2004.
22. Leon SC, Snowden J, Bryant FB, Lyons JS: The hospital as predictor of children's and adolescents' length of stay. J Am Acad Child Adolesc Psychiatry 45:322-328, 2006.
23. Lyons JS: Severity of Psychiatric Illness Scale: Child and Adolescent Version. San Antonio (Texas), Psychological Corp, 1998.
24. Lyons JS, Howard KI, O'Mahoney MT, Lish JD: The Measurement and Management of Clinical Outcomes in Mental Health. New York, Wiley & Sons, 1997.
25. Martin A, Leslie D: Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000. Am J Psychiatry 160:757-764, 2003.
26. McDermott BM, McKelvey R, Roberts L, Davies L: Severity of children's psychopathology and impairment and its relationship to treatment setting. Psychiatr Serv 53:57-62, 2002.
27. Najjar F, Welch C, Grapentine WL, Sachs H, Siniscalchi J, Price LH: Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998. J Child Adolesc Psychopharmacol 14:87-93, 2004.
28. Pappadopulos E, Jensen PS, Schur SB, MacIntyre JC, Ketner S, Van Orden K, Sverd J, Sardana S, Woodlock D, Schweitzer R, Rube D: "Real world" atypical antipsychotic prescribing patterns in public child and adolescent inpatient settings. Schizophr Bull 28:111-121, 2002.
29. th ed. Montvale (New Jersey), Thompson PDR, 2006.
30. Pogge DL, Singer MB, Harvey PD: Rates and predictors of adherence with atypical antipsychotic medication: A follow-up study of adolescent inpatients. J Child Adolesc Psychopharmacol 15:901-912, 2005.
31. Pottick KJ, McAlpine D, Andelman R: Changing patterns of psychiatric inpatient care for children and adolescents, 1988-1995. Am J Psychiatry 157:1267-1273, 2000.
32. Raghavan R, Zima BT, Andersen RM, Leibowitz AA, Schuster MA, Landsverk J: Psychotropic medication use in a national probability sample of children in the child welfare system. J Child Adolesc Psychopharmacol 15:97-106, 2005.
33. Ryan ND, Bhatara VS, Perel JM: Mood stabilizers in children and adolescents. J Am Acad Child Adolesc Psychiatry 38:529-536, 1999.
34. Safer DJ, Zito JM, dosReis S: Concomitant psychotropic medication for youths. Am J Psychiatry 160:438-449, 2003.
35. Schur S, Sikich L, Findling R, Malone R, Crismon M, Derivan A: Treatment recommendations for the use of antipsychotic medications for aggressive youth (TRAAY) part one: Review of relevant literature. J Am Acad Child Adolesc Psychiatry 42:132-144, 2003.
36. SPSS, Inc: SPSS Professional Statistics. Chicago, 2005.
37. Turner S, Nunn AJ, Fielding K, Choonara I: Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: A prospective study. Acta Paediatr 88:965-968, 1999.
38. Warner LA, Pottick KJ, Bilder S: Clinical and organizational correlates of psychotropic medication use among youths in outpatient mental health services in the U.S. Soc Serv Rev 79:454-481, 2005.
39. Waxmonsky JG, Wilens TE: Pharmacotherapy of adolescent substance use disorders: A review of the literature. J Child Adolesc Psychopharmacol 15:810-825, 2005.
40. Wilens TE, Spencer TJ, Frazier J, Biederman J: Child and adolescent psychopharmacology. In: Handbook of Child Psychopathology. Edited by Ollendick TH, Hersen M. New York, Plenum Press, 1998, pp 603-640.
41. Wolraich ML, Wibbelsman CJ, Brown TE, Evans SW, Gotlieb EM, Knight JR, Ross EC, Shubiner HH, Wender EH, Wilens T: Attention-Deficit/Hyperactivity Disorder among adolescents: A review of the diagnosis, treatment, and clinical implications. Pediatrics 115:1734-1746, 2005.
42. Zima BT, Bussing R, Crecelius GM, Kaufman A, Belin TR: Psychotropic medication treatment patterns among school-aged children in foster care. J Child Adolesc Psychopharmacol 9:135-147, 1999.